PTC Therapeutics And DMD: STRIVE Patient Advocacy Grant Program
PTC Therapeutics, a New Jersey biopharmaceutical company, announces this month, that the company is launching a new grant awards program, STRIVE (Strategies to Realize Innovation, Vision, and Empowerment). The purpose of the program, which will focus on Duchenne Muscular Dystrophy (DMD) for 2015, is to provide funds to nonprofit patient advocacy organizations for the support of new programs that will benefit the DMD community through:
• Improving diagnosis & treatment of DMD patients
• Educating public & healthcare professionals
• Increase visibility of DMD
• Identify & foster next generation of DMD patient advocates.
Five one-year awards of up to $30,000 each will be given to the proposals identified by a panel of judges. The deadline for proposal submission is June 22, 2015, with the awards being announced on World Duchenne Awareness Day, September 7, 2015.
To receive detailed information about the application and submission process, one can send an E-Mail, with “STRIVE Award Process” in the subject line, to STRIVE@ptcbio.com.
Copyright © 2012-2015, Orphan Druganaut Blog. All rights reserved.